Remarkably, these metabolic genes are implicated in understanding the etiology of ovarian cancer and the development of targeted therapies against these growth factors (e.g. EGFR), to improve chemotherapy outcomes in ovarian cancer patients. The gene discussed is EGFR; the disease is ovarian cancer.